(Adds analyst comments in paragraphs 4 & 6, details throughout) By Christy Santhosh Sept 11 (Reuters) – AstraZeneca's breast cancer pill failed to meet the main goal of improving progression-free
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)